샘플 요청 목록

 카트 문의
시장보고서
상품코드
1874623

세계의 조제 약국 시장

Compounding Pharmacy
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 187 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 조제 약국 시장은 2030년까지 197억 달러에 달할 전망

세계의 조제 약국 시장은 2024년에 152억 달러로 추정되고 있으며, 2024-2030년의 분석 기간에 CAGR 4.5%로 성장하며, 2030년까지 197억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석 대상 부문의 하나인 경구 제품은 5.2%의 CAGR을 기록하며, 분석 기간 종료시까지 86억 달러에 달할 것으로 예측됩니다. 외용 제품 부문의 성장률은 분석 기간에 4.3%의 CAGR로 추정되고 있습니다.

미국 시장은 42억 달러로 추정되는 한편, 중국은 4.3%의 CAGR로 성장할 것으로 예측됩니다.

미국의 조제 약국 시장은 2024년에 42억 달러로 추정되고 있습니다. 세계 2위의 경제 규모를 자랑하는 중국은 2024-2030년의 분석 기간에 CAGR 4.3%로 추이하며, 2030년까지 31억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장 분석으로는 일본과 캐나다를 들 수 있으며, 분석 기간 중 각각 CAGR 4.4%, 3.5%로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 3.5%의 CAGR로 성장할 것으로 예측됩니다.

세계의 조제 약국 시장 - 주요 시장 동향과 촉진요인의 개요

조제약국은 현대 헬스케어에서 맞춤형 의료를 어떻게 실현하고 있는가?

조제 약국은 환자 개개인의 특정 요구에 맞는 맞춤형 의약품을 제공함으로써 현대 의료에서 중요한 역할을 담당하고 있습니다. 대량 생산된 의약품과 달리 조제 의약품은 약사가 성분을 혼합하고 환자의 고유한 요구 사항에 따라 제형, 강도 또는 성분을 조정하는 맞춤형 치료법입니다. 이는 알레르기, 정제 삼키기 어려움 또는 대량 생산 의약품이 충족할 수 없는 특정 용량 요구로 인해 일반 의약품을 복용할 수 없는 환자들에게 특히 중요합니다. 조제약국에서 조제되는 의약품은 피부과, 소아과, 통증관리, 호르몬 대체요법 등 다양한 의료 분야에서 활용되고 있습니다. 최근 환자 및 의료진이 개인의 건강 상태에 맞는 보다 정밀한 치료를 요구하면서 맞춤형 의료에 대한 수요가 증가하고 있습니다. 이러한 변화는 표준 의약품 제조로는 충족할 수 없는 니즈를 충족시키는 조제 약국의 중요성이 증가하고 있으며, 환자 치료와 치료 결과를 향상시키는 개인화된 의료 접근 방식을 제공합니다.

기술 혁신은 조제 약국의 관행을 어떻게 변화시키고 있는가?

조제 약국 실무는 최첨단 기술을 통해 크게 발전하여 맞춤형 의약품을 보다 효율적이고 정확하며 안전하게 조제할 수 있게 되었습니다. 자동화는 가장 혁신적인 발전 중 하나이며, 자동 조제 시스템을 통해 유효 성분의 정밀한 계량이 가능해져 인적 오류를 줄이고 생산 속도를 향상시켰습니다. 이는 오염이 심각한 위험을 초래할 수 있는 무균 제제의 제조에 특히 중요합니다. 또한 의약품 소프트웨어의 발전으로 조제 약사는 업무 흐름을 효율화하고, 보다 정확한 기록 관리, 우수한 재고 관리 및 규제 표준 준수를 보장할 수 있게 되었습니다. 디지털 플랫폼을 통해 약사는 약물 상호 작용 및 환자 알레르기 정보를 신속하게 대조할 수 있으며, 조제 의약품의 안전성과 유효성을 더욱 향상시킬 수 있습니다. 경피 흡수 젤, 속방성 정제, 서방형 제제 등 첨단 제제 기술을 활용하여 환자에게 제공할 수 있는 치료법의 폭을 넓히고, 보다 유연하고 혁신적인 약물 투여 방법을 실현하고 있습니다. 또한 제약 분야에서의 3D 프린팅 기술의 부상은 조제 업무에 영향을 미치기 시작했으며, 정확한 용량과 모양으로 개인화된 의약품을 인쇄할 수 있는 잠재력을 가지고 있습니다. 이를 통해 맞춤형 치료로 달성할 수 있는 영역이 더욱 확대되고 있습니다. 이러한 기술 혁신은 조제 의약품의 품질과 접근성을 향상시키고, 개인 맞춤형 치료의 확장성과 신뢰성을 높이고 있습니다.

조제약국은 다양한 분야의 다양한 헬스케어 니즈에 어떻게 대응하고 있는가?

조제약국은 기존 의약품으로는 대응하기 어려운 분야에서 다양한 헬스케어 니즈에 대응하는 솔루션을 제공합니다. 예를 들어 소아과 분야에서 조제 약국은 시중에서 구하기 어려운 개별 조정된 용량을 제공하고, 약사가 액상, 향료, 츄어블 등의 제형을 준비하여 어린이가 쉽게 복용할 수 있도록 돕습니다. 피부과 분야에서는 건선, 습진, 여드름 등 특정 피부질환에 대응하는 맞춤형 크림, 연고, 젤을 제조하고, 여러 유효성분을 배합하여 단일 제품 내에서 종합적인 치료를 실현합니다. 통증 관리도 조제약국이 중요한 역할을 하는 분야입니다. 특히 만성 통증 환자들은 오피오이드, 근이완제, 항염증약 등의 약물을 전신성 부작용을 최소화하기 위해 맞춤형 용량과 경피 흡수패치 등의 투여방법으로 조정된 정밀한 배합이 요구됩니다. 호르몬 대체요법(HRT)에서도 조제 약국은 중요한 역할을 합니다. 갱년기 및 기타 내분비 불균형을 겪는 환자의 호르몬 요구에 따라 생체 동일성 호르몬을 개별적으로 배합하여 최적의 용량을 설정합니다. 또한 조제 약국은 수의학 분야에서도 자주 활용되고 있습니다. 동물용 의약품은 용량과 제형에 따라 개별적으로 조정해야 하며, 복약 순응도를 높이기 위해 향을 첨가하는 경우도 있습니다. 이러한 다양한 분야에서 조제약국은 기존 의약품으로는 적절한 치료법을 찾기 어려운 환자들의 특정 니즈를 충족시킬 수 있는 맞춤형 솔루션을 제공합니다.

조제 약국 시장의 성장을 가속하는 요인은 무엇인가?

조제 약국 시장의 성장은 의료 수요의 진화와 제약 관행의 발전을 반영하는 여러 요인에 의해 주도되고 있습니다. 주요 촉진요인 중 하나는 맞춤형 의료에 대한 수요 증가입니다. 환자와 의료진은 특정 증상, 알레르기, 선호도에 따라 보다 맞춤화된 치료를 원하고 있습니다. 이러한 추세는 호르몬 대체요법(HRT), 통증 관리, 소아 의료 등의 분야에서 특히 두드러지는데, 표준 용량과 제형으로는 환자의 요구를 충족시키지 못하는 경우가 많습니다. 또 다른 중요한 요인은 대형 제약사의 특정 의약품 공급 부족 및 생산 중단입니다. 이로 인해 의료 서비스 프로바이더들은 환자의 지속적인 치료를 보장하기 위해 부족한 부분을 보충하는 수단으로 조제 약국에 의존하게 되었습니다. 또한 규제 변화 및 대량 생산 의약품의 안전성 및 유효성에 대한 우려(특히 리콜 및 의약품 부족 문제)로 인해 대체 솔루션을 제공하는 조제 약국에 대한 의존도가 높아지고 있습니다. 조제 과정에 자동화를 도입하고 환자 데이터 관리 디지털 툴을 강화하는 등 기술적 진보도 조제 의약품의 생산 효율성과 정확성을 높여 시장 성장을 촉진하고 있습니다. 또한 의료비 상승과 선진국의 고령화 인구 증가로 인해 보다 개인화되고 저렴한 치료법에 대한 수요가 증가하고 있으며, 조제 약국은 이러한 치료법을 제공하는 데 있으며, 독보적인 강점을 발휘하고 있습니다. 마지막으로 기존 의약품 시장에서 구하기 어려운 솔루션을 제공하는 조제약국의 역할이 수의학 분야에서 인정받고 있는 것도 조제약국 시장 확대에 기여하고 있습니다. 이러한 요인들이 결합되어 개인화된 헬스케어 솔루션의 중요한 요소로서 조제 약국의 지속적인 성장을 가속하고 있습니다.

부문 :

부문(경구, 외용, 주사제, 비강용, 직장용, 안과용, 기타 부문), 유통 채널(병원 약국, 조제 약국, 기타 유통 채널)

조사 대상 기업의 예

  • B. Braun Melsungen AG
  • Dougherty's Pharmacy, Inc.
  • Fagron NV
  • Fresenius Kabi AG
  • Village Compounding Pharmacy
  • Wedgewood Pharmacy

AI 통합

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석을 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM이나 산업 전문 SLM에 대한 쿼리 방식을 대신하여 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색엔진 조사, 그리고 방대한 양의 기업, 제품/서비스, 시장 데이터가 포함됩니다.

관세 영향 계수

이번 보고서에는 Global Industry Analysts가 예측한 본사 소재지, 생산기지, 수출입(완제품 및 OEM)에 따른 기업의 경쟁력 변화에 따라 지역 시장에 미치는 관세의 영향을 반영했습니다. 이러한 복잡하고 다면적인 시장 현실은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학을 통해 경쟁사들에게 영향을 미칠 것입니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계의 기타 지역

제4장 경쟁

KSA

Global Compounding Pharmacy Market to Reach US$19.7 Billion by 2030

The global market for Compounding Pharmacy estimated at US$15.2 Billion in the year 2024, is expected to reach US$19.7 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Oral Products, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$8.6 Billion by the end of the analysis period. Growth in the Topical Products segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.2 Billion While China is Forecast to Grow at 4.3% CAGR

The Compounding Pharmacy market in the U.S. is estimated at US$4.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2030 trailing a CAGR of 4.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Compounding Pharmacy Market - Key Trends and Drivers Summarized

How Are Compounding Pharmacies Tailoring Personalized Medicine for Modern Healthcare?

Compounding pharmacies play a critical role in modern healthcare by providing customized medications tailored to the specific needs of individual patients. Unlike mass-produced pharmaceuticals, compounded medications are created by pharmacists who mix ingredients to form personalized treatments, adjusting dosage forms, strengths, or ingredients based on a patient’s unique requirements. This is particularly important for patients who cannot take commercially available medications due to allergies, difficulty swallowing pills, or specific dosage needs that are not available in mass-produced drugs. Compounded medications are used across a wide range of medical fields, including dermatology, pediatrics, pain management, and hormone replacement therapy. In recent years, the demand for personalized medicine has increased, as patients and healthcare providers seek more precise treatments that cater to individual health conditions. This shift highlights the growing importance of compounding pharmacies in filling the gaps left by standard pharmaceutical manufacturing, offering a personalized approach to medicine that enhances patient care and outcomes.

How Are Technological Advances Revolutionizing Compounding Pharmacy Practices?

The practice of compounding pharmacy has seen significant advancements, driven by cutting-edge technologies that have made the preparation of customized medications more efficient, accurate, and safe. Automation has been one of the most transformative developments, with automated compounding systems allowing for precise measurements of active ingredients, reducing human error, and increasing the speed of production. This is especially crucial in the preparation of sterile compounds, where any contamination can pose significant risks. Furthermore, advancements in pharmaceutical software have enabled compounding pharmacists to streamline their workflows, ensuring more accurate record-keeping, better inventory management, and compliance with regulatory standards. Digital platforms now allow pharmacists to cross-reference drug interactions and patient allergies quickly, further enhancing the safety and efficacy of compounded medications. The use of advanced compounding techniques, such as transdermal gels, rapid-dissolve tablets, and sustained-release formulations, has expanded the range of treatments available to patients, offering more flexible and innovative ways to deliver medications. Additionally, the rise of 3D printing technology in pharmaceuticals is beginning to influence compounding practices, with the potential to print personalized medications in precise dosages and forms, further pushing the boundaries of what can be achieved in tailored treatments. These technological innovations are improving the quality and accessibility of compounded medications, making personalized treatments more scalable and reliable.

How Is Compounding Pharmacy Serving Diverse Healthcare Needs Across Various Fields?

Compounding pharmacies cater to a diverse range of healthcare needs, providing solutions in areas where traditional pharmaceutical products may fall short. In pediatrics, for instance, compounded medications offer tailored dosages that are often unavailable in mass-market drugs, and pharmacists can prepare formulations in liquid, flavored, or chewable forms to make them more palatable for children. In dermatology, compounding pharmacies produce customized creams, ointments, and gels that address specific skin conditions such as psoriasis, eczema, and acne, often blending multiple active ingredients to create a comprehensive treatment in a single product. Pain management is another field where compounding pharmacies are vital, especially for patients with chronic pain who require precise formulations of medications such as opioids, muscle relaxants, or anti-inflammatories in customized doses or delivery methods, such as topical creams or transdermal patches, to minimize systemic side effects. Hormone replacement therapy (HRT) is another area where compounding pharmacies excel, creating individualized doses of bioidentical hormones tailored to the hormonal needs of patients undergoing menopause or other endocrine imbalances. Furthermore, compounding pharmacies are often relied upon in veterinary medicine, where medications for animals must be tailored in terms of dosage and formulation, sometimes flavored to ensure compliance. Across these various fields, compounding pharmacies offer personalized solutions that meet the specific needs of patients who might otherwise struggle to find appropriate treatments through conventional pharmaceuticals.

What Are the Factors Behind the Growth of the Compounding Pharmacy Market?

The growth in the compounding pharmacy market is driven by several factors, reflecting both the evolving needs of healthcare and advancements in pharmaceutical practices. One of the key drivers is the increasing demand for personalized medicine, as patients and healthcare providers seek more individualized treatments tailored to specific conditions, allergies, and preferences. This trend is particularly strong in fields like hormone replacement therapy (HRT), pain management, and pediatric care, where standard dosages and formulations often do not meet patient needs. Another significant factor is the shortage or discontinuation of certain medications from large pharmaceutical manufacturers, which has led healthcare providers to turn to compounding pharmacies to fill the gaps and ensure continued treatment for their patients. Additionally, regulatory changes and concerns about the safety and effectiveness of mass-produced medications, particularly with recalls or drug shortages, have spurred greater reliance on compounding pharmacies to provide alternative solutions. Technological advancements, such as the introduction of automation in compounding processes and enhanced digital tools for managing patient data, are also driving market growth by increasing the efficiency and accuracy of compounded drug production. Furthermore, the rise in healthcare costs and the growing number of aging populations in developed regions are pushing demand for more tailored and affordable treatment options, which compounding pharmacies are uniquely positioned to provide. Lastly, the increasing awareness of compounding’s role in veterinary medicine, offering solutions that are often not available in the traditional pharmaceutical market, is expanding the scope of the compounding pharmacy market. Together, these factors are contributing to the sustained growth of compounding pharmacies as a critical element of personalized healthcare solutions.

SCOPE OF STUDY:

The report analyzes the Compounding Pharmacy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Segment (Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic, Other Segments); Distribution Channel (Hospital Pharmacy, Compounding Pharmacy, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 27 Featured) -

  • B. Braun Melsungen AG
  • Dougherty's Pharmacy, Inc.
  • Fagron NV
  • Fresenius Kabi AG
  • Village Compounding Pharmacy
  • Wedgewood Pharmacy

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Compounding Pharmacy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Chronic Diseases Expands Addressable Market for Customized Compounded Medications
    • Increasing Demand for Personalized Medicine Propels Growth of Compounding Pharmacies
    • Advancements in Pharmaceutical Compounding Strengthen the Business Case for Precision Dosage Solutions
    • Growing Focus on Pediatric and Geriatric Care Spurs Demand for Tailored Compounded Medications
    • Shortages of Commercially Available Drugs Throw the Spotlight on Compounding Pharmacies for Alternative Solutions
    • Rising Demand for Hormone Replacement Therapy (HRT) Accelerates Growth of Compounded Pharmacy Services
    • Emerging Need for Allergen-Free and Preservative-Free Medications Expands Opportunities for Compounding Pharmacies
    • Surge in Demand for Bio-Identical Hormones and Custom Pain Management Solutions Strengthens Business Case for Compounding
    • Rising Focus on Niche Therapies, Including Dermatology and Ophthalmology, Expands Market for Specialty Compounded Medications
    • Technological Innovations in Sterile Compounding Propel Growth of Safe and Efficient Compounded Medication Services
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Compounding Pharmacy Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Compounding Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Nasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Nasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Nasal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Rectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Rectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Rectal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Ophthalmic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Ophthalmic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Ophthalmic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Hospital Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Compounding Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Compounding Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
  • JAPAN
    • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
  • CHINA
    • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
  • EUROPE
    • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Compounding Pharmacy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Compounding Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
  • FRANCE
    • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
  • GERMANY
    • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Compounding Pharmacy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Compounding Pharmacy by Segment - Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of World 15-Year Perspective for Compounding Pharmacy by Segment - Percentage Breakdown of Value Sales for Oral, Topical, Parenteral, Nasal, Rectal, Ophthalmic and Other Segments for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Compounding Pharmacy by Distribution Channel - Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Compounding Pharmacy by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Compounding Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제